Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.
about
Loss of Niemann Pick type C proteins 1 and 2 greatly enhances HIV infectivity and is associated with accumulation of HIV Gag and cholesterol in late endosomes/lysosomesLipid composition and fluidity of the human immunodeficiency virus.Cholesterol-dependent membrane fusion induced by the gp41 membrane-proximal external region-transmembrane domain connection suggests a mechanism for broad HIV-1 neutralization.Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes.The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine designJuxtamembrane protein segments that contribute to recruitment of cholesterol into domainsAn emerging complimentary medicine-yolk oil made from heating method.Preparation and use of liposomes in the treatment of microbial infections.Pathogenesis of human immunodeficiency virus infection and prospects for control.Treatment of AIDS with drugs targeted to inhibit different stages of the HIV life cycle.The past, present, and future uses of liposomes in treating infectious diseases.Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane.Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring.
P2860
Q21245090-C17AC503-B7F3-4C12-8325-A4F67207FFD1Q34048036-9718ED17-FE80-4404-8A8D-7F60CEDCAE87Q34594591-8FEB74A2-BF4C-46AD-855A-6B0700FFE8F3Q35610321-6B0E81B7-7308-4B2C-9DC9-E4036656030AQ36342211-FBA42240-063B-409A-BFE9-C0323D7C1399Q36497712-5ACF594C-5363-4A24-90F1-6BC8CE2508E7Q36836452-8D581EB9-C5EB-402D-AF36-5706E930B4DBQ37618095-996AA032-A3A0-43AB-83B3-AC46AD389704Q39654122-3733987D-5D11-4F61-ACAE-DBB6A966C46FQ39692591-C35EBE87-4477-499C-B934-91BBEFAD8C89Q40468453-D6213A57-6B4C-4201-B917-095A68BFF37BQ40530985-CC6EBB10-FCC7-4DCF-9B66-E24AE7D41B85Q40792231-D0CDEDDF-9582-402C-B5D4-94DFDE31DDB0Q43945296-BBE3236E-1BE4-42C2-A9BE-67CF91BC2CD6
P2860
Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.
@en
Effects of a novel compound
@nl
type
label
Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.
@en
Effects of a novel compound
@nl
prefLabel
Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.
@en
Effects of a novel compound
@nl
P2093
P1476
Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.
@en
P2093
P304
P356
10.1056/NEJM198511143132011
P407
P50
P577
1985-11-01T00:00:00Z